These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8566484)

  • 41. Quinolones in children. Are concerns over arthropathy justified?
    Stahlmann R; Förster C; Van Sickle D
    Drug Saf; 1993 Dec; 9(6):397-403. PubMed ID: 8129861
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of increasing doses of enrofloxacin on chicken articular cartilage.
    Maślanka T; Jaroszewski JJ; Mikołajczyk A; Rotkiewicz T
    Pol J Vet Sci; 2009; 12(1):21-33. PubMed ID: 19459436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of toxicokinetic variables and arthropathic changes in juvenile rabbits after oral administration of an investigational fluoroquinolone, PD 117596.
    Johnson RJ; Black WD; Sigler RE; Baragi VM; Gough AW
    Am J Vet Res; 2000 Nov; 61(11):1396-402. PubMed ID: 11108186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
    Thuong-Guyot M; Domarle O; Pocidalo JJ; Hayem G
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1544-9. PubMed ID: 7996468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats.
    Förster C; Kociok K; Shakibaei M; Merker HJ; Vormann J; Günther T; Stahlmann R
    Arch Toxicol; 1996; 70(5):261-70. PubMed ID: 8852696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes.
    Egerbacher M; Wolfesberger B; Gabler C
    Vet Pathol; 2001 Mar; 38(2):143-8. PubMed ID: 11280370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
    Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quinolone-induced cartilage lesions are not reversible in rats.
    Förster C; Kociok K; Shakibaei M; Merker HJ; Stahlmann R
    Arch Toxicol; 1996; 70(8):474-81. PubMed ID: 8783810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs.
    Yoshida K; Yabe K; Nishida S; Yamamoto N; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Pharmacol Ther; 1998 Apr; 21(2):128-32. PubMed ID: 9597650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
    Postnikov SS; Semykin SIu; Nazhimov VP; Novichkova GA
    Antibiot Khimioter; 2002; 47(9):14-7. PubMed ID: 12619515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of temafloxacin neurotoxicity in rodents.
    Giardina WJ
    Am J Med; 1991 Dec; 91(6A):42S-44S. PubMed ID: 1662895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-reactivity between quinolones. Report of three cases.
    Dávila I; Diez ML; Quirce S; Fraj J; De La Hoz B; Lazaro M
    Allergy; 1993 Jul; 48(5):388-90. PubMed ID: 8368469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents.
    Guzmán A; García C; Demestre I
    Arzneimittelforschung; 1999 May; 49(5):448-56. PubMed ID: 10367108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs.
    Yabe K; Murakami Y; Nishida S; Sekiguchi M; Furuham K; Goryo M; Okada K
    J Vet Med Sci; 2001 Aug; 63(8):867-72. PubMed ID: 11558541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats.
    Kato M; Takada S; Kashida Y; Nomura M
    Toxicol Pathol; 1995; 23(3):385-92. PubMed ID: 7659960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H; Kawamura Y
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic effect of fleroxacin against experimental pneumonia in mice.
    Niki Y; Watanabe M; Tasaka Y; Umeki S; Soejima R
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():129-31. PubMed ID: 3144531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.